<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?covid-19-tdm?>
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2022.877232</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of the COVID-19 Pandemic on the Work Activity of Spanish Physical Therapists and Their Response to Vaccination</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Montero-Navarro</surname> <given-names>Sergio</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1682256/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>S&#x000E1;nchez-M&#x000E1;s</surname> <given-names>Jes&#x000FA;s</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1680354/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Salar-Andreu</surname> <given-names>Cristina</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Molina-Pay&#x000E1;</surname> <given-names>Francisco Javier</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1786797/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Orts-Ruiz</surname> <given-names>Cristina</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1786809/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Botella-Rico</surname> <given-names>Jos&#x000E9; Martin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tuells</surname> <given-names>Jos&#x000E9;</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1130836/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Rodr&#x000ED;guez-Blanco</surname> <given-names>Noelia</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1785763/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Nursing and Physical Therapy Department, Health Sciences Faculty, CEU-Cardenal Herrera University, CEU Universities</institution>, <addr-line>Elche</addr-line>, <country>Spain</country></aff>
<aff id="aff2"><sup>2</sup><institution>Biomedical Sciences Department, Health Sciences Faculty, CEU-Cardenal Herrera University, CEU Universities</institution>, <addr-line>Elche</addr-line>, <country>Spain</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Community Nursing, Preventive Medicine and Public Health and History of Science, University of Alicante</institution>, <addr-line>Alicante</addr-line>, <country>Spain</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Obstetrics and Gynaecology, Marina Baixa University Hospital</institution>, <addr-line>Villajoyosa</addr-line>, <country>Spain</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Taner Bayraktaroglu, B&#x000FC;lent Ecevit University, Turkey</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Maria Teresa Caetano Tom&#x000E1;s, Escola Superior de Tecnologia da Sa&#x000FA;de de Lisboa (ESTeSL), Portugal; Luigi De Maria, University of Bari Aldo Moro, Italy</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Jes&#x000FA;s S&#x000E1;nchez-M&#x000E1;s <email>jesus.sanchez&#x00040;uchceu.es</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Occupational Health and Safety, a section of the journal Frontiers in Public Health</p></fn></author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>877232</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Montero-Navarro, S&#x000E1;nchez-M&#x000E1;s, Salar-Andreu, Molina-Pay&#x000E1;, Orts-Ruiz, Botella-Rico, Tuells and Rodr&#x000ED;guez-Blanco.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Montero-Navarro, S&#x000E1;nchez-M&#x000E1;s, Salar-Andreu, Molina-Pay&#x000E1;, Orts-Ruiz, Botella-Rico, Tuells and Rodr&#x000ED;guez-Blanco</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Due to the COVID-19 pandemic, physical therapists have had to adopt a set of specific protection measures, which have had an impact on their clinical activity and economy. The objective was to evaluate the impact of the COVID-19 pandemic on the work of Spanish physical therapists, as well as their attitudes and predisposition to vaccination. An online questionnaire was divided into five sections: (<xref ref-type="bibr" rid="B1">1</xref>) demographic and professional data; (<xref ref-type="bibr" rid="B2">2</xref>) labor impact; (<xref ref-type="bibr" rid="B3">3</xref>) precautions and infection-control measures; (<xref ref-type="bibr" rid="B4">4</xref>) economic impact; and (<xref ref-type="bibr" rid="B5">5</xref>) vaccine acceptance and adverse effects. Of the 666 participants, 62.1% showed a reduction in their working hours motivated by: fear of infection (<italic>p</italic> = 0.007), financial issues (<italic>p</italic> = 0.002) and being in quarantine or isolation (<italic>p</italic> &#x0003C; 0.001). Of these, 36.4% were forced to close the clinic, 62.7% requested help from the government, but only 12.04% mentioned that it was adequate. The main prevention measures adopted were the use of gels and masks and, in the private sector, disinfection with ozone or ultraviolet light (<italic>p</italic> &#x0003C; 0.05). The acceptance of the vaccine was high, 87.5%, being lower among the group over 40 years of age, self-employed, widowed or separated. More adverse effects were mentioned after receiving the AstraZeneca-Oxford vaccine, compared to Pfizer-BioNTech or Moderna. In conclusion, this study assessed for the first time that the COVID-19 pandemic in Spain had a negative impact on work and finances of physical therapists. The vaccine was widely accepted, in part by the economic impact that an infection in the work setting could signify.</p></abstract>
<kwd-group>
<kwd>vaccines</kwd>
<kwd>physical therapists</kwd>
<kwd>COVID-19</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>acceptance</kwd>
<kwd>impact</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="54"/>
<page-count count="12"/>
<word-count count="8581"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>On March 11th, 2020, the World Health Organization (WHO) declared a world pandemic due to the fast, worldwide propagation of the virus named SARS-CoV-2, which produced the disease named COVID-19 (<xref ref-type="bibr" rid="B1">1</xref>). From that moment on, Spain was one of the most-affected countries, with a total number of 87,462 confirmed deaths and 5,019,255 confirmed cases (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Spain announced a state of alarm on March 14th, 2020, through the Royal Decree 463/2020 (<xref ref-type="bibr" rid="B4">4</xref>), which included restrictions such as limitations on movement of people, cancelation of public events, isolation and quarantine, among others.</p>
<p>The expansion of the virus created a saturation in the health system, placing the collective of health professionals, among which we find physical therapists, in a very complicated situation (<xref ref-type="bibr" rid="B5">5</xref>&#x02013;<xref ref-type="bibr" rid="B7">7</xref>). The physical therapist clinics could only remain open to tend to emergencies, without being able to close, as they were considered essential health professionals. Also, given the close physical contact between the patient and the therapist (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>), the physical therapists had to adopt a set of specific protection measures to perform their professional care activities, such as: the use of personal protection equipment (PPE), telephone-based triage, questionnaire for the detection of COVID-19 patients, reduction of patients/day, disinfection of hands, ventilation between patients, limits in companions, use of aerosol filters, among others. This situation had an enormous economic impact on the private clinics, who had to absorb the cost associated with these new measures. Also, the fear of the population of becoming infected notably reduced the activity of these physical therapy clinics (<xref ref-type="bibr" rid="B10">10</xref>). On May 4th, 2020, a de-escalation plan approved by the government was initiated, which progressively reduced the restrictions and lasted until September 2020 (<xref ref-type="bibr" rid="B11">11</xref>). However, it was not until May 9th, 2021, that the state of alarm ended (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>In the meantime, the restrictions were modified as a function of the health situation associated to the COVID-19 pandemic, and therefore, the clinics also had to adapt to guarantee the safety of the patients and workers. Faced with this scenario, many of the Spanish physical therapists who worked in private clinics decided to close their clinics and ask for State-funded aid (<xref ref-type="bibr" rid="B13">13</xref>). However, the concession of these aid packages was not ensured, as the Spanish Government established that private health clinics were an essential activity that must remain open, although they were only authorized to provide emergency care, as indicated in the Royal Decree 09/2020 from March 28th (<xref ref-type="bibr" rid="B14">14</xref>), and the Royal Decree 10/2020 from March 29th (<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>On the other hand, the only strategy that was able to stop the spread of the virus was to achieve herd immunity in the entire country, either through vaccination, natural infections, or a mix of both (<xref ref-type="bibr" rid="B16">16</xref>). In Spain, the vaccination campaign begun on December 27th, 2020, and according to the vaccination strategy, the first to receive it would be individuals who were institutionalized and its workers, front-line health professionals, social health workers, and dependent individuals (<xref ref-type="bibr" rid="B3">3</xref>). As for the physical therapists, the Spanish government started the vaccination of those who worked in the public health system, who were provided the Pfizer-BioNTech (PB) vaccine.</p>
<p>After the vaccination of the public health physical therapists, the private mutual insurance companies managed the administration of the vaccines to the workers who worked in private healthcare, who received the AstraZenexa-Oxford (AZ) vaccine. During this period, physical therapists were also given an appointment for vaccination according to their age groups and were able to receive any of the available vaccines. This management resulted in differences among professionals, in both the date of vaccination and the type of vaccine received. Afterwards, on March 16th, 2021, the Spanish government decided to temporarily suspend the vaccination with AZ due to the appearance of cerebral thrombosis and other secondary effects (<xref ref-type="bibr" rid="B17">17</xref>), with a great number of private healthcare physical therapists without a first dose or without being able to complete the vaccination against COVID-19. The vaccination campaign resumed a few weeks after, and the physical therapists with the first AZ dose were allowed to choose between AZ or PB to complete the vaccination schedule, under informed consent (<xref ref-type="bibr" rid="B18">18</xref>). This led to uncertainty in the physical therapist collective, which led to increased reticence and the decrease in the acceptance of the second dose of the vaccine among Spanish physical therapists.</p>
<p>In this regard, it is necessary to assess in Spain the impact of the pandemic due to COVID-19 on physical therapists during the state of alarm decreed by the Spanish government, to discover the decisions and measures adopted by these professionals associated with the work setting and their decision to become vaccinated.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>Design, Population, and Sample</title>
<p>A cross-sectional survey was conducted using an electronic questionnaire that was electronically sent to Spanish physical therapists by the General Council of Physical Therapist Associations of Spain, starting on June 8th, 2021, and ending on June 28th, 2021. The total number of registered Spanish physiotherapists in 2021 was 45.061, which was used as the reference population. The calculated sample size was equal to 381, with a level of confidence of 95%, and a margin of error of 5% (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>).</p>
</sec>
<sec>
<title>Data-Collection Tool</title>
<p>A questionnaire designed <italic>ad hoc</italic>, based on a previously published survey (<xref ref-type="bibr" rid="B21">21</xref>), was utilized as the data-collection instrument, and a pilot study was conducted with a group of 25 physical therapists, who were not considered for this analysis. This pilot study allowed us to collect the impressions of those polled, and the questionnaires were afterwards evaluated by a group of experts to assess the understanding of the questions by the respondents and to determine how long it took them to complete it, and to check the internal consistency of all questionnaire&#x00027;s components. The final questionnaire was composed of 23 closed-ended or ten-point Likert scale questions.</p>
<p>These questions were divided into five sections: (<xref ref-type="bibr" rid="B1">1</xref>) six questions designed to collect demographic and professional data (age, sex, marital status, employment, years of work experience, professional role); (<xref ref-type="bibr" rid="B2">2</xref>) two questions about the impact in the professional sector and the triggers; (<xref ref-type="bibr" rid="B3">3</xref>) two questions about practice modification, the precautions and infection-control measures against COVID-19 infection; (<xref ref-type="bibr" rid="B4">4</xref>) five questions assessed the economic impact in the health care activity, and the soliciting and concession of State-funded aid; and (<xref ref-type="bibr" rid="B5">5</xref>) eight questions about the impact of COVID-19, acceptance of the vaccine, adverse effects of the vaccine, and reasons for accepting the vaccine. The voluntary consent, objectives of the study, the code of acceptance from the ethics committee, and the estimated length of time needed to complete the questionnaire were included on the questionnaire heading. A total of 692 questionnaires were obtained, with a final sample of 666 due to the exclusion of 26 incomplete questionnaires.</p>
</sec>
<sec>
<title>Methods of Analysis</title>
<p>The mean &#x000B1; standard deviation was utilized for the quantitative variables, and frequency tables for the qualitative data. The Chi-square test was utilized to investigate the relationships between the categorical variables. The factors associated to the willingness to receive the vaccine were identified through the use a logistic regression analysis. A multivariate logistic regression was performed with the 581 participants who claimed to have received the vaccine, in order to identify the adverse effects associated with the type of vaccine received, with the odds ratio (OR) probability and a confidence interval (CI) of 95% calculated. The likelihood was calculated with the Wald Chi-square test, and the goodness-of-fit was tested with Pearson&#x00027;s test. The statistical analysis was performed with the IBM SPSS Statistics software program for Windows, version 24.0.</p>
</sec>
<sec>
<title>Ethical Considerations</title>
<p>The study was conducted in accordance with the principles from the Declaration of Helsinki on human clinical trials (Ref No. 579/06/2020) and was approved by the Ethics Committee from the CEU Cardenal-Herrera University (CEI21/060).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Demographic and Professional Data</title>
<p>A total of 666 physical therapists completed the questionnaire, of which 72.1% (<italic>n</italic> = 480) were women. Their mean age was 32.8 years old, and 69.4% (<italic>n</italic> = 462) lived with a partner. Their mean work experience was 9.8 years, with a distribution of mainly private sector workers, 90.3% (<italic>n</italic> = 602), including freelancers and self-employed individuals. With respect to the professional role, 15.2% (<italic>n</italic> = 101) were employers, and the rest employees or freelancers (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Demographic and professional data of the physical therapists (<italic>n</italic> = 666).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Variables</bold></th>
<th valign="top" align="center"><bold>Findings</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sex</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Female</td>
<td valign="top" align="center">480 (72.1)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Male</td>
<td valign="top" align="center">186 (27.9)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Age (years)</td>
<td valign="top" align="center">32.8 &#x000B1; 7.0</td>
</tr>
<tr>
<td valign="top" align="left">Age group</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;20&#x02013;29 years</td>
<td valign="top" align="center">254 (38.1)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;30&#x02013;39 years</td>
<td valign="top" align="center">281 (42.2)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x0003E;40 years</td>
<td valign="top" align="center">131 (19.7)</td>
</tr>
<tr>
<td valign="top" align="left">Marital status</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Single</td>
<td valign="top" align="center">185 (27.8)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Married</td>
<td valign="top" align="center">193 (29.0)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Living with a partner</td>
<td valign="top" align="center">269 (40.4)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Divorced/Widowed</td>
<td valign="top" align="center">19 (2.8)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Work experience (years)</td>
<td valign="top" align="center">9.8 &#x000B1; 6.9</td>
</tr>
<tr>
<td valign="top" align="left">Group work experience</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0; &#x0003C;5 years</td>
<td valign="top" align="center">190 (28.5)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;5&#x02013;10 years</td>
<td valign="top" align="center">192 (28.8)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;11&#x02013;15 years</td>
<td valign="top" align="center">138 (20.7)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x0003E;16 years</td>
<td valign="top" align="center">146 (21.9)</td>
</tr>
<tr>
<td valign="top" align="left">Type of employment</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;State / interim worker</td>
<td valign="top" align="center">44 (6.6)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Freelancer</td>
<td valign="top" align="center">324 (48.6)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Self-employed</td>
<td valign="top" align="center">278 (41.7)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Sick leave /unemployed</td>
<td valign="top" align="center">20 (3.0)</td>
</tr>
<tr>
<td valign="top" align="left">Professional role</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Employer</td>
<td valign="top" align="center">101 (15.2)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Employee/freelancer</td>
<td valign="top" align="center">556 (83.5)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;No answer</td>
<td valign="top" align="center">9 (1.4)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data shown as number of responses (percentage)</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Impact on the Physical Therapist Work During the Pandemic</title>
<p>From the total participating physical therapists, 62.1% (<italic>n</italic> = 401) mentioned a reduction in their scheduled appointments, as compared to 31.6% (<italic>n</italic> = 204) who kept the same number of patients, despite the restrictions and conditions marked by the pandemic. With regards to those who indicated a reduction in their work schedule, they were asked for the reasons behind this change (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Reasons provided by the physical therapists that resulted in the reduction of scheduled appointments during the pandemic.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpubh-10-877232-g0001.tif"/>
</fig>
<p>The main reasons were; fear or worry of the patients of becoming infected at the clinic (68.2%), being in quarantine due to a close contact with a COVID-19 case, or due to the infection of the patient (66.1%). Other reasons provided were the decision to reduce the appointment schedule to guarantee the safety of the patients and workers (52.5%), the limits placed on mobility (17.2%), or economic reasons (37.7%).</p>
<p>Among the physical therapists who affirmed to have suffered a reduction in appointments (<italic>n</italic> = 401), 92.0% (<italic>n</italic> = 369) worked in the private sector, and 8.0% (<italic>n</italic> = 32) in the public one. The statistical analysis showed that the reduction in the work schedule of the physical therapists who worked in the private sector, as compared to those who worked in the public sector, was greatly influenced by the variables &#x0201C;fear of infection of the patient&#x0201D; (<italic>p</italic> = 0.007), &#x0201C;the discomfort of the patient with the new safety measures implemented&#x0201D; (<italic>p</italic> = 0.047), &#x0201C;economic reasons&#x0201D; (<italic>p</italic> = 0.002), and due to &#x0201C;quarantine or infection of the patients&#x0201D; (<italic>p</italic> &#x0003C; 0.001). The rest of the statements did not show significant differences between the public and private sectors.</p>
</sec>
<sec>
<title>Modification of Practices Associated to the Precautions and Infection-Control Measures Against COVID-19 Infection</title>
<p>The PPE, the hygiene measures, and the safety measures incorporated by the physical therapists who worked in the private and public sectors are shown in <xref ref-type="table" rid="T2">Table 2</xref>. For the physical therapists who remained active, the main PPEs and hygiene measures incorporated to the clinical practice were the use of alcohol-water gels (95.7%) and the FFP2 or FFP3 masks (92.7%). Other measures implemented were the use of surgical masks (65.8%), gloves (64.7%), and protection goggles or screens (57.0%), as well as leaving a period of time between patients to ventilate and disinfect the room (74.0%). The measures of use of ozone (9.4%) or ultraviolet light (3.4%) were less-utilized by the physical therapists, as well as the periodic testing for COVID-19 through PCR or antigen tests, by neither the companies (12.1%) nor the physical therapist (10.4%).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Personal protection equipment, hygiene measures, and safety measures incorporated at work during the pandemic by the physical therapists.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th valign="top" align="left"><bold>Total<xref ref-type="table-fn" rid="TN2"><sup>&#x0002A;&#x0002A;</sup></xref>(<italic>n</italic> &#x0003D; 646)</bold></th>
<th valign="top" align="center"><bold>Private sector (<italic>n</italic> &#x0003D; 602)</bold></th>
<th valign="top" align="center"><bold>Public sector (<italic>n</italic> &#x0003D; 44)</bold></th>
<th valign="top" align="center"><bold>Chi<sup><bold>2</bold></sup> value</bold></th>
<th valign="top" align="center"><bold><italic>p</italic></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="6"><bold>Personal protection equipment incorporated at work</bold></td>
</tr>
<tr>
<td valign="top" align="left">FFP2 or FFP3 masks</td>
<td valign="top" align="center">599 (92.7)</td>
<td valign="top" align="center">557 (92.5)</td>
<td valign="top" align="center">42 (95.5)</td>
<td valign="top" align="center">0.52</td>
<td valign="top" align="center">0.470</td>
</tr>
<tr>
<td valign="top" align="left">Surgical masks</td>
<td valign="top" align="center">425 (65.8)</td>
<td valign="top" align="center">396 (65.8)</td>
<td valign="top" align="center">29 (65.9)</td>
<td valign="top" align="center">&#x0003C;0.01</td>
<td valign="top" align="center">0.986</td>
</tr>
<tr>
<td valign="top" align="left">Gloves</td>
<td valign="top" align="center">418 (64.7)</td>
<td valign="top" align="center">393 (65.3)</td>
<td valign="top" align="center">25 (56.8)</td>
<td valign="top" align="center">1.29</td>
<td valign="top" align="center">0.257</td>
</tr>
<tr>
<td valign="top" align="left">Goggles or protection screens</td>
<td valign="top" align="center">368 (57.0)</td>
<td valign="top" align="center">343 (57.0)</td>
<td valign="top" align="center">25 (56.8)</td>
<td valign="top" align="center">&#x0003C;0.01</td>
<td valign="top" align="center">0.984</td>
</tr>
<tr>
<td valign="top" align="left">Disposable gown</td>
<td valign="top" align="center">276 (42.7)</td>
<td valign="top" align="center">259 (43.0)</td>
<td valign="top" align="center">17 (38.6)</td>
<td valign="top" align="center">0.32</td>
<td valign="top" align="center">0.570</td>
</tr>
<tr>
<td valign="top" align="left">Disposable shoe covers</td>
<td valign="top" align="center">113 (17.5)</td>
<td valign="top" align="center">105 (17.4)</td>
<td valign="top" align="center">8 (18.2)</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">0.901</td>
</tr>
<tr>
<td valign="top" align="left">Disposable caps</td>
<td valign="top" align="center">103 (15.9)</td>
<td valign="top" align="center">92 (15.3)</td>
<td valign="top" align="center">11 (25.0)</td>
<td valign="top" align="center">2.89</td>
<td valign="top" align="center">0.089</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6"><bold>Hygiene or safety measures incorporated at work</bold></td>
</tr>
<tr>
<td valign="top" align="left">Water-alcohol gels</td>
<td valign="top" align="center">618 (95.7)</td>
<td valign="top" align="center">577 (95.8)</td>
<td valign="top" align="center">41 (93.2)</td>
<td valign="top" align="center">0.70</td>
<td valign="top" align="center">0.402</td>
</tr>
<tr>
<td valign="top" align="left">Time between patients</td>
<td valign="top" align="center">478 (74.0)</td>
<td valign="top" align="center">446 (74.1)</td>
<td valign="top" align="center">32 (72.7)</td>
<td valign="top" align="center">0.04</td>
<td valign="top" align="center">0.843</td>
</tr>
<tr>
<td valign="top" align="left">Not seeing two patients at the same time</td>
<td valign="top" align="center">264 (40.9)</td>
<td valign="top" align="center">247 (41.0)</td>
<td valign="top" align="center">17 (38.6)</td>
<td valign="top" align="center">0.10</td>
<td valign="top" align="center">0.755</td>
</tr>
<tr>
<td valign="top" align="left">Ventilation and disinfection of the rooms</td>
<td valign="top" align="center">253 (39.2)</td>
<td valign="top" align="center">237 (39.4)</td>
<td valign="top" align="center">16 (36.4)</td>
<td valign="top" align="center">0.16</td>
<td valign="top" align="center">0.693</td>
</tr>
<tr>
<td valign="top" align="left">Air filtration equipment</td>
<td valign="top" align="center">151 (23.4)</td>
<td valign="top" align="center">143 (23.8)</td>
<td valign="top" align="center">8 (18.2)</td>
<td valign="top" align="center">0.71</td>
<td valign="top" align="center">0.399</td>
</tr>
<tr>
<td valign="top" align="left">PCR test of oneself</td>
<td valign="top" align="center">67 (10.4)</td>
<td valign="top" align="center">67 (11.1)</td>
<td valign="top" align="center">0 (0.0)</td>
<td valign="top" align="center">5.46</td>
<td valign="top" align="center">0.019 <xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">Company provides PCR test</td>
<td valign="top" align="center">78 (12.1)</td>
<td valign="top" align="center">75 (12.5)</td>
<td valign="top" align="center">3 (6.8)</td>
<td valign="top" align="center">1.23</td>
<td valign="top" align="center">0.268</td>
</tr>
<tr>
<td valign="top" align="left">Disinfection with ozone</td>
<td valign="top" align="center">61 (9.4)</td>
<td valign="top" align="center">61 (10.1)</td>
<td valign="top" align="center">0 (0.0)</td>
<td valign="top" align="center">4.92</td>
<td valign="top" align="center">0.026 <xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">Ultraviolet light</td>
<td valign="top" align="center">21 (3.3)</td>
<td valign="top" align="center">21 (3.5)</td>
<td valign="top" align="center">0 (0.0)</td>
<td valign="top" align="center">4.34</td>
<td valign="top" align="center">0.046 <xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data shown as n (%)</italic>.</p>
<fn id="TN1"><label>&#x0002A;</label><p><italic>p &#x0003C;0.05 Chi square calculated as contingency table</italic>.</p></fn>
<fn id="TN2"><label>&#x0002A;&#x0002A;</label><p><italic>Population calculated after eliminating those who were sick leave or unemployed (n &#x0003D; 646)</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The statistical test only showed significant differences between the private and public sectors with respect to the use of ozone or ultraviolet light disinfection, as well as one&#x00027;s own decision to take a PCR test.</p>
</sec>
<sec>
<title>Economic Impact of the Health Care Activity of the Private Sector Physical Therapists</title>
<p>The participants were asked about the economic impact of the pandemic experienced by the physical therapists who worked in the private sector (<italic>n</italic> = 602) during the state of alarm period, from March 14th, 2020 to May 9th, 2021. Of the participants, 36.4% (<italic>n</italic> = 219) was forced to close the clinic during the pandemic periods in which work was allowed. Also, of the 62.7% (<italic>n</italic> = 377) who solicited the economic aid from the Spanish government, most were granted, except for 8.0% which were rejected. When analyzing the opinion of the physical therapists who received the aid, 12.04% (<italic>n</italic> = 72) affirmed that the aid completely covered the economic impact during the state of alarm period, while 56.3% (<italic>n</italic> = 339) indicated that it was not sufficient.</p>
<p>Finally, when asked about the economic impact associated to the pandemic period according to a Likert scale, which range from 0 (no economic impact) to 10 (maximum economic impact), the physical therapists who worked in the private sector referred to an economic impact of 5.9 &#x000B1; 2.5 with respect to the previous years.</p>
</sec>
<sec>
<title>Attitudes Toward Vaccination and the Current State of Health</title>
<p>As for the impact of COVID-19 infection between the participating physical therapists, 15.5% (<italic>n</italic> = 103) declared that they had recovered from the disease, and 32.9% (<italic>n</italic> = 219) had to be quarantined at home due to infection or being a close contact with a person infected with COVID-19 (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Impact of COVID-19, vaccine acceptance and adverse effects of vaccination.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Variables</bold></th>
<th valign="top" align="center"><bold>Findings</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Have you been infected with COVID-19?</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">103 (15.5)</td>
</tr>
<tr>
<td valign="top" align="left">Were you quarantined?</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">219 (32.9)</td>
</tr>
<tr>
<td valign="top" align="left">Have you received the COVID-19 vaccine?</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;No</td>
<td valign="top" align="center">85(12.8)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Rejected</td>
<td valign="top" align="center">35 (5.3)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;It was not offered to me</td>
<td valign="top" align="center">50 (7.5)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">581 (87.2)</td>
</tr>
<tr>
<td valign="top" align="left">What vaccine was used as the first dose? (<italic>n</italic> = 581)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;AZ</td>
<td valign="top" align="center">406 (61.0)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;PB</td>
<td valign="top" align="center">141 (21.2)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Mo</td>
<td valign="top" align="center">34 (5.1)</td>
</tr>
<tr>
<td valign="top" align="left">Did you receive a second dose? Which one (<italic>n</italic> = 581)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;No</td>
<td valign="top" align="center">221 (38.0)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Waiting</td>
<td valign="top" align="center">136 (61.5)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;It was not offered to me</td>
<td valign="top" align="center">50 (22.6)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Rejected</td>
<td valign="top" align="center">35 (15.8)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">445 (62.0)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;AZ</td>
<td valign="top" align="center">259 (58.2)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;PB</td>
<td valign="top" align="center">161 (36.2)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Mo</td>
<td valign="top" align="center">25 (5.6)</td>
</tr>
<tr>
<td valign="top" align="left">Any adverse effects after vaccination? (<italic>n</italic> = 581)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">528 (90.9)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Pain in the arm</td>
<td valign="top" align="center">471 (81.1)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Tiredness</td>
<td valign="top" align="center">365 (62.8)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Fever</td>
<td valign="top" align="center">290 (49.9)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Headache</td>
<td valign="top" align="center">274 (47.2)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Generalized muscle pain</td>
<td valign="top" align="center">268 (46.1)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Shivering</td>
<td valign="top" align="center">245 (42.2)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Inflammation of the ganglia</td>
<td valign="top" align="center">47 (8.1)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Vomiting</td>
<td valign="top" align="center">31 (5.3)</td>
</tr>
<tr>
<td valign="top" align="left">Would you accept a second dose? (<italic>n</italic> = 115)<xref ref-type="table-fn" rid="TN3"><sup>&#x0002A;</sup></xref></td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes, even if it&#x00027;s a different brand</td>
<td valign="top" align="center">28 (24.3)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes, but only if it&#x00027;s the same brand</td>
<td valign="top" align="center">80 (69.6)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;No, under no circumstances</td>
<td valign="top" align="center">4 (3.5)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;I don&#x00027;t know</td>
<td valign="top" align="center">3 (2.6)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data shown as n (%)</italic>.</p>
<fn id="TN3"><label>&#x0002A;</label><p><italic>percentage calculated with respect to the total number of participants who received the first AZ dose and were waiting to receive the second one. AZ, AstraZeneca-Oxford; PB, Pfizer-BioNTech; Mo, Moderna</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The acceptance of the vaccine was greatly favorable, as 87.2% (<italic>n</italic> = 581) indicated having received the AZ, PB, or Moderna (Mo) vaccines. Most were vaccinated with AZ (61.1%) in the first round, with PB being the second most-common vaccine administered (21.2%). With respect to the second dose, 20 more physical therapists received PB in the second round instead of AZ. There were 136 participants (20.4%) who were still waiting for the second dose. Of these, 10 participants received PB in the first dose, 11 received Mo, and 115 received AZ. Of the total number of participants vaccinated with the AZ vaccine as a first dose, most would accept the same vaccine only if they received the same one (69.6%), and only 28 participants (24.3%) would receive a different one. A rejection of the second dose was observed in 3.5% of those who were vaccinated with the first dose of AZ.</p>
<p>The most frequent adverse effect among those vaccinated was pain in the place where the vaccine was administered (81.1%), followed by tiredness (62.8%). The percent was calculated considering that only 581 indicated having been vaccinated. The adverse effects with a frequency close to 50% were fever (47.2%), headache (47.2%), generalized muscle soreness (46.1%), and shivering (42.4%). The inflammation of ganglia or vomiting were observed with a frequency lower than 10%. Only 53 participants (9.1%) indicated not suffering from any of the symptoms mentioned previously.</p>
<p>The multivariate logistic regression performed with the 581 participants who had received the vaccine showed that the administration of the AZ vaccine was associated with a greater appearance of headaches (<italic>p</italic> = 0.002) and shivering (<italic>p</italic> &#x0003C; 0.001) with respect to the administration of the PB vaccine (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p>Multivariate logistic regression analyses showing adverse effects associated to the vaccine brand received by the physical therapists who participated in the study.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Adverse effects</bold></th>
<th valign="top" align="center"><bold>AZ (<italic>n</italic> &#x0003D; 406)</bold></th>
<th valign="top" align="center"><bold>PB (<italic>n</italic> &#x0003D; 141)</bold></th>
<th valign="top" align="center"><bold>OR (95% CI)</bold></th>
<th valign="top" align="center"><bold><italic>p</italic></bold></th>
<th valign="top" align="center"><bold>Mo (<italic>n</italic> &#x0003D; 34)</bold></th>
<th valign="top" align="center"><bold>OR (95% CI)</bold></th>
<th valign="top" align="center"><bold><italic>p</italic></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Pain at the place where the vaccine was administered</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">330 (81.3)</td>
<td valign="top" align="center">112 (79.4)</td>
<td valign="top" align="center">1.61 (0.77&#x02013;3.36)</td>
<td valign="top" align="center">0.203</td>
<td valign="top" align="center">29 (85.3)</td>
<td valign="top" align="center">0.93 (0.30&#x02013;2.90)</td>
<td valign="top" align="center">0.894</td>
</tr>
<tr>
<td valign="top" align="left">Fever</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">231 (56.9)</td>
<td valign="top" align="center">44 (31.2)</td>
<td valign="top" align="center">0.67 (0.40&#x02013;1.13)</td>
<td valign="top" align="center">0.132</td>
<td valign="top" align="center">15 (44.1)</td>
<td valign="top" align="center">1.43 (0.60&#x02013;3.40)</td>
<td valign="top" align="center">0.421</td>
</tr>
<tr>
<td valign="top" align="left">Headache</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">219 (53.9)</td>
<td valign="top" align="center">42 (29.8)</td>
<td valign="top" align="center">0.49 (0.31&#x02013;0.77)</td>
<td valign="top" align="center">0.002<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">13 (38.2)</td>
<td valign="top" align="center">0.69 (0.32&#x02013;1.50)</td>
<td valign="top" align="center">0.351</td>
</tr>
<tr>
<td valign="top" align="left">Vomiting</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">28 (6.9)</td>
<td valign="top" align="center">2 (1.4)</td>
<td valign="top" align="center">0.48 (0.11&#x02013;2.13)</td>
<td valign="top" align="center">0.332</td>
<td valign="top" align="center">1 (2.9)</td>
<td valign="top" align="center">1.22 (0.14&#x02013;10.5)</td>
<td valign="top" align="center">0.858</td>
</tr>
<tr>
<td valign="top" align="left">Tiredness</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">264 (65.0)</td>
<td valign="top" align="center">82 (58.2)</td>
<td valign="top" align="center">1.48 (0.89&#x02013;2.44)</td>
<td valign="top" align="center">0.129</td>
<td valign="top" align="center">18 (52.9)</td>
<td valign="top" align="center">0.92 (0.42&#x02013;2.05)</td>
<td valign="top" align="center">0.844</td>
</tr>
<tr>
<td valign="top" align="left">Shivering</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">208 (51.2)</td>
<td valign="top" align="center">29 (20.6)</td>
<td valign="top" align="center">0.34 (0.20&#x02013;0.58)</td>
<td valign="top" align="center">&#x0003C;0.001<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">8 (23.5)</td>
<td valign="top" align="center">0.32 (0.12&#x02013;0.82)</td>
<td valign="top" align="center">0.017<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">Generalized muscle pain</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">212 (52.2)</td>
<td valign="top" align="center">50 (35.5)</td>
<td valign="top" align="center">0.90 (0.54&#x02013;1.49)</td>
<td valign="top" align="center">0.678</td>
<td valign="top" align="center">6 (17.6)</td>
<td valign="top" align="center">0.23 (0.08&#x02013;0.62)</td>
<td valign="top" align="center">0.004<xref ref-type="table-fn" rid="TN4"><sup>&#x0002A;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">Inflammation of the ganglia</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Yes</td>
<td valign="top" align="center">36 (8.9)</td>
<td valign="top" align="center">6 (4.3)</td>
<td valign="top" align="center">0.56 (0.22&#x02013;1.44)</td>
<td valign="top" align="center">0.229</td>
<td valign="top" align="center">5 (14.7)</td>
<td valign="top" align="center">0.12 (0.01&#x02013;1.22)</td>
<td valign="top" align="center">0.353</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data shown as n (percent within the vaccine brand). OR = calculated for each answer as compared to all the others; p = calculated for the Chi-square test group. The negative response to the presence of the adverse effect was taken as the reference value for the multivariate logistic regression analysis. AZ, AstraZeneca-Oxford; PB, Pfizer-BioNTech. Mo, Moderna</italic>.</p>
<fn id="TN4"><label>&#x0002A;</label><p><italic>p &#x0003C;0.05 Chi-square calculated as contingency table</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Likewise, the administration of the AZ vaccine was associated with a greater appearance of shivering (<italic>p</italic> = 0.017) and generalized muscle soreness (<italic>p</italic> = 0.004) with respect to the administration of Mo. For the rest, the adverse effects did not show significant differences according to the vaccine received.</p>
<p>The analysis of the influence of the sociodemographic or work characteristics on the acceptance or rejection of the COVID-19 vaccine by the participating physical therapists is shown in <xref ref-type="table" rid="T5">Table 5</xref>. Thus, the physical therapists who rejected the COVID-19 vaccine to a higher extent were older than 40 years old, divorced/widowed, and freelancers.</p>
<table-wrap position="float" id="T5">
<label>Table 5</label>
<caption><p>Profile of the physical therapist who accepts or rejects the COVID-19 vaccine.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Variables</bold></th>
<th valign="top" align="center"><bold>Total (<italic>n</italic> &#x0003D; 616)</bold></th>
<th valign="top" align="center"><bold>Acceptance group (<italic>n</italic> &#x0003D; 581)</bold></th>
<th valign="top" align="center"><bold>Rejection group (<italic>n</italic> &#x0003D; 35)</bold></th>
<th valign="top" align="center"><bold>Chi<sup><bold>2</bold></sup> value</bold></th>
<th valign="top" align="center"><bold><italic>p</italic></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sex</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">0.30</td>
<td valign="top" align="center">0.586</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Female</td>
<td valign="top" align="center">447 (72.6)</td>
<td valign="top" align="center">423 (94.6)</td>
<td valign="top" align="center">24 (5.4)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Male</td>
<td valign="top" align="center">169 (27.4)</td>
<td valign="top" align="center">158 (93.5)</td>
<td valign="top" align="center">11 (6.5)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Age group</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">10.14</td>
<td valign="top" align="center">0.006<xref ref-type="table-fn" rid="TN5"><sup>&#x0002A;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;20&#x02013;29 years</td>
<td valign="top" align="center">230 (37.3)</td>
<td valign="top" align="center">223 (97.0)</td>
<td valign="top" align="center">7 (3.0)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;30&#x02013;39 years</td>
<td valign="top" align="center">261 (42.4)</td>
<td valign="top" align="center">247 (94.6)</td>
<td valign="top" align="center">14 (5.4)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x0003E;40 years</td>
<td valign="top" align="center">125 (20.3)</td>
<td valign="top" align="center">111 (88.8)</td>
<td valign="top" align="center">14 (11.2)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Marital status</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Single</td>
<td valign="top" align="center">166 (29.6)</td>
<td valign="top" align="center">161 (97.0)</td>
<td valign="top" align="center">5 (3.0)</td>
<td valign="top" align="center">27.76</td>
<td valign="top" align="center">&#x0003C;0.001<xref ref-type="table-fn" rid="TN5"><sup>&#x0002A;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Married</td>
<td valign="top" align="center">177 (28.7)</td>
<td valign="top" align="center">164 (92.7)</td>
<td valign="top" align="center">13 (7.3)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;In couple</td>
<td valign="top" align="center">254 (41.2)</td>
<td valign="top" align="center">243 (95.7)</td>
<td valign="top" align="center">11 (4.3)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Divorced/Widowed</td>
<td valign="top" align="center">19 (3.1)</td>
<td valign="top" align="center">13 (68.4)</td>
<td valign="top" align="center">6 (31.6)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Group work experience</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">4.89</td>
<td valign="top" align="center">0.180</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0; &#x0003C;5 years</td>
<td valign="top" align="center">171 (27.8)</td>
<td valign="top" align="center">163 (95.3</td>
<td valign="top" align="center">8 (4.7)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;5&#x02013;10 years</td>
<td valign="top" align="center">178 (28.9)</td>
<td valign="top" align="center">192 (28.8)</td>
<td valign="top" align="center">192 (28.8)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;11&#x02013;15 years</td>
<td valign="top" align="center">130 (21.1)</td>
<td valign="top" align="center">121 (93.1)</td>
<td valign="top" align="center">9 (6.9)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x0003E;16 years</td>
<td valign="top" align="center">137 (22.2)</td>
<td valign="top" align="center">125 (91.2)</td>
<td valign="top" align="center">12 (34.3)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Type of employment</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;State / interim</td>
<td valign="top" align="center">44 (7.1)</td>
<td valign="top" align="center">40 (90.9)</td>
<td valign="top" align="center">4 (9.1)</td>
<td valign="top" align="center">8.55</td>
<td valign="top" align="center">0.036<xref ref-type="table-fn" rid="TN5"><sup>&#x0002A;</sup></xref></td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Freelancer</td>
<td valign="top" align="center">294 (47.7)</td>
<td valign="top" align="center">272 (92.5)</td>
<td valign="top" align="center">22 (7.5)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Self-employed</td>
<td valign="top" align="center">262 (42.5)</td>
<td valign="top" align="center">255 (97.3)</td>
<td valign="top" align="center">7 (2.7)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Not actives</td>
<td valign="top" align="center">16 (2.6)</td>
<td valign="top" align="center">14 (87.5)</td>
<td valign="top" align="center">2 (12.5)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Professional role</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Employer</td>
<td valign="top" align="center">511 (83.0)</td>
<td valign="top" align="center">90 (92.8)</td>
<td valign="top" align="center">26 (5.1)</td>
<td valign="top" align="center">0.72</td>
<td valign="top" align="center">0.396</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Employee/freelancer</td>
<td valign="top" align="center">97 (15.7)</td>
<td valign="top" align="center">485 (94.9)</td>
<td valign="top" align="center">7 (7.2)</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;No answer</td>
<td valign="top" align="center">8 (1.3)</td>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data shown as number of responses (percentage)</italic>.</p>
<fn id="TN5"><label>&#x0002A;</label><p><italic>p &#x0003C; 0.05 Chi-square calculated as contingency table</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Reasons Provided for Accepting the COVID-19 Vaccine</title>
<p>The main reasons for vaccination were the need to protect others and oneself, along with the belief that vaccines were good for health. The fear of social distancing or the existence of a COVID-19 passport were not found among the main reasons for the vaccine acceptance of the physical therapists (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Reasons provided for COVID-19 vaccine acceptance.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpubh-10-877232-g0002.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>According to our knowledge, this is the first study conducted in Spain that evaluated the impact of the pandemic due to COVID-19 on physical therapists during the state of alarm decreed by the Spanish government, as well as the acceptance of the vaccine by this group of healthcare professionals.</p>
<sec>
<title>Impact on Work Among Spanish Physical Therapists</title>
<p>Among the participating physical therapists who were actively working, 62.1% indicated a reduction in the work schedule, with an economic impact of 5.9 &#x000B1; 2.5 on a 10-point Likert scale. The reduction in the work schedule observed among the Spanish physical therapists is comparable to other countries such as the United States, where the clinical practices suffered a 60% decrease in the volume of patients and a 55% decrease in income due to COVID-19 (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Other examples include Iraq, where odontologists suffered economic losses of about 50% (<xref ref-type="bibr" rid="B24">24</xref>), and Romania, where the decrease in patients in the clinics consulted resulted in a decrease of their income of about 72.5% (<xref ref-type="bibr" rid="B21">21</xref>). This number increases to 100% in the Spanish odontology clinics (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>The main reasons given for the decrease in patient care in consultations were to guarantee the safety of patients and worker (52.5%) (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B25">25</xref>). We must add the strict security measures imposed by the Government, and the scarcity or high prices of the protection equipment needed to meet these safety measures, which greatly aggravated the work and economic impact experienced by the clinics (<xref ref-type="bibr" rid="B26">26</xref>&#x02013;<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>As shown in this study, most of the physical therapist professionals in Spain worked as freelancers or in small or medium enterprises (<xref ref-type="bibr" rid="B30">30</xref>). As the measures to contain the spread of the virus broadened, the economic impact on the private clinics was greater, and could be translated as loss of employment and qualitative and quantitative changes in care provision (<xref ref-type="bibr" rid="B31">31</xref>). In this sense, the physical therapists consulted who worked in the private sector indicated that their schedule was more reduced with respect to those who worked in the public sector. Also, during the state of alarm, physical therapists were considered as a basic service to treat only emergency situations, while the non-emergency healthcare activities that were scheduled were suspended (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B32">32</xref>). This forced many private physical therapist clinics to close (36.4%), and most of the professionals (62.7%) had to ask for Government aid, of which 8% were rejected.</p>
<p>The emergency funds for freelancers, according to Decree 1/2020 and 44/2020 (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), were destined to workers who were registered since December 31st, 2019 and with a reduction in income of 75%, with the individual quantity being between 750 and 1,500 in the case of many communities, such as the Community of Valencia, and which were compatible with the reductions in the Social Security contributions and the supplementary allowance due to cessation of activities (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>Finally, self-employed workers who prove the total cessation or a 75% decrease in their activity compared to the previous quarter, may suspend or modify their supply contracts. Free medical insurance was offered from the different physiotherapist colleges that covered hospital admission for COVID-19 (<xref ref-type="bibr" rid="B36">36</xref>). However, the majority of those who received the aid (56.3%) stated that it was not enough to cover their needs, and only 12% indicated that the aid fully covered the economic impact during the state of alarm. For this reason, it is necessary to carry out an in-depth study to analyze the economic impact of the pandemic on private clinics and determine whether the emergency aid promoted by the Government was sufficient.</p>
<p>Another factor that influenced the reduction in the working hours of physical therapists in the private sector was the discomfort perceived by patients due to the security measures implemented in their clinics. As expected, the use of hydroalcoholic gel and masks, FFP2 and FFP3, were the most common measures (&#x0003E;90%), both in the public and private sectors. These measures were mandatory for both patients and health professionals, by mandate of the Ministry of Health (<xref ref-type="bibr" rid="B37">37</xref>). At the national level, these COVID prevention and control measures and the Vaccination Strategy applied to the socio-occupational situation of the individual have proven to be efficient and reach workers with the highest risk of COVID-19 early.</p>
<p>However, the physical therapists who worked in the private sector were more worried about their own health and that of their patients, and therefore implemented additional measures, such as the room disinfection devices using ozone or ultraviolet light. Working in private clinics was associated with the fear of having to close the clinic due to COVID-19 infection, which would perhaps lead to important economic losses, despite COVID-19 infection described in the Royal Decree 6/2020, from May 10th, as a common disease associated to a work accident, and the emergency measures adopted in the area of economy. This circumstance could have influenced the increased worry of the health professionals for avoiding infection of patients or employees in their private clinics, although this could result in an increase in the costs associated to the implementation of more safety measures in a period of economic recession.</p>
</sec>
<sec>
<title>Acceptance of the Vaccine and the Attitudes of the Physical Therapists</title>
<p>The data showed a great acceptance of the first dose of the COVID-19 vaccine among the Spanish physical therapists consulted in June 2021 (87.2%). Like that observed in the general Spanish population (<xref ref-type="bibr" rid="B20">20</xref>), our study identified age, marital status, and employment as factors that influenced the decision of the physical therapists to accept or reject the COVID-19 vaccine. The high acceptance shown in our study was validated by a positive attitude among the physical therapists with respect to the belief of the protective effect of the COVID-19 vaccine and vaccines in general.</p>
<p>These results are similar as that obtained in May 2021 in Spain in a study conducted with 664 health professionals, whom, without differentiating between specialties, showed a vaccine acceptance rate of 79.4% (<xref ref-type="bibr" rid="B38">38</xref>). In both cases, the acceptance of the vaccine among Spanish health professionals was higher than that estimated in December 2020, in two studies conducted just before the start of the vaccination campaign (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B39">39</xref>). In these previous studies, health workers were consulted on their intention to become vaccinated, with an estimation of acceptance of 52% among health professionals (<xref ref-type="bibr" rid="B20">20</xref>), specifically, an intention of vaccination of 82.5% among doctors, and 65.4% among nurses (<xref ref-type="bibr" rid="B39">39</xref>), always below the 87.2% found for the physical therapists who accepted the first dose in our study.</p>
<p>It seems to be the case that as the vaccination campaign progressed, the increase in the confidence of the COVID-19 vaccine among physical therapists increased, not only in Spain, but also in the rest of the world (<xref ref-type="bibr" rid="B40">40</xref>&#x02013;<xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>Among the adverse effects described by the physical therapists, the most frequent were pain in the area where the vaccine was given, tiredness, headache, as well as fever and generalized muscle pain. Just as our data show, localized pain after the injection seemed to be the most frequent adverse effect after the administration of the vaccine in the health professional population (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>) as well as the general population (<xref ref-type="bibr" rid="B45">45</xref>&#x02013;<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>The type of adverse effect observed among physical therapists was similar to that of other health professionals (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B47">47</xref>), although the frequency of appearance showed variations in some studies, especially if we compared them with the non-health professional population (<xref ref-type="bibr" rid="B48">48</xref>). We should take into account that it is less probable for health professionals to report the adverse effects at the beginning of the study, given their clinical experience and their ability to self-evaluate the severity of the disease (<xref ref-type="bibr" rid="B49">49</xref>). Only 9.1% of the vaccinated physical therapists indicated not suffering from any of the symptoms mentioned. This percentage is somewhat lower if we compare it to other health professionals such as Spanish nephrologists (25%) (<xref ref-type="bibr" rid="B40">40</xref>), although it is similar to health professionals from South Korea (7.3%) (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>The two main brands administered to the participating Spanish physical therapists were AZ (61.1%) and PB (21.2%). Our study shows a greater appearance of adverse systemic effects such as headache (53.9%), shivering (51.2%) and generalized muscle pain (52.2%) in the physical therapists who received the AZ vaccine as compared to the other vaccines administered. This greater appearance of adverse effects was also found in other health workers who were vaccinated with the AZ vaccine as opposed to RNAm vaccines such as PB or Mo (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>Aside from the increased adverse effects, the administration of the AZ vaccine was associated with adverse events such as thrombocytopenia and thrombosis, which were not frequent although severe (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). This situation led to the suspension of the vaccination campaign with the AZ vaccine in Spain due to the increase in the secondary effects described (<xref ref-type="bibr" rid="B17">17</xref>), and the decision of many countries to suspend its use. This damaged the perception of the safety of the AZ vaccine in Spain and surrounding countries (<xref ref-type="bibr" rid="B51">51</xref>). In our study, 3.5% of the physical therapists who received the first dose of AZ confirmed that they would not accept a second dose under any circumstance. This percentage of rejection was higher than that observed in Spain in May of 2021 among health professionals (2.1%) and the general population (1.5%) (<xref ref-type="bibr" rid="B38">38</xref>). This scenario of mistrust, mainly created by the adverse events associated to the AZ vaccine, led to the Spanish Ministry of Health agreeing that those younger than 60 who were vaccinated with one dose of AZ would be vaccinated, through a heterologous regime, with a second dose of PB, to avoid the appearance of thrombotic effects (<xref ref-type="bibr" rid="B52">52</xref>).</p>
<p>In contrast to the Spanish Government, the European Medicines Agency, supported by many Spanish health professionals through communication media, recommended the continuation with the AZ vaccine as a first and second dose at any age starting with 18 years of age, as the benefits were clearly greater than the adverse reactions (<xref ref-type="bibr" rid="B53">53</xref>). The results shown in the present study indicate that the physical therapists who received the first dose of the AZ vaccine would accept the second dose only in the case of having received the AZ vaccine (69.6%), and only 28 of the participants (24.3%) would accept another brand.</p>
<p>These data suggest that the physical therapists considered the scientific recommendations from the European Medicines Agency to a greater degree than those from the Spanish Government. This trust in favor of health and scientific institutions as opposed to the political positions, has been previously described among the Spanish population at the start of the vaccination campaign against COVID-19 (<xref ref-type="bibr" rid="B20">20</xref>). This demonstrates the importance of achieving a good coordination between the political and health institutions to provide information jointly, precisely, transparently, and correctly to the population, to guarantee a greater percentage of acceptance of the vaccine, which would allow reaching the immunity desired as soon as possible, to fight against the pandemic caused by COVID-19. This is valuable information to consider in future, similar scenarios.</p>
</sec>
<sec>
<title>Limitations of the Study</title>
<p>Our study did not quantify the impact on work with respect to economic losses. The impact on work was evaluated from the consultation with health professionals regarding the decrease in scheduled appointments, the perceived economic impact and the factors that influence it. It would be necessary to carry out a quantitative study to obtain a numerical reference of the economic impact of the COVID-19 pandemic among physiotherapy clinics.</p>
<p>It is interesting that those working in the private sector compared to the public sector were more influenced by fear and discomfort of the new security measures, it could be a limitation that the study population was more than 90% physical therapists working in the private sector.</p>
<p>One of the limitations of our study was that a validated questionnaire was not found, which is not available in the scientific literature since COVID-19 is an emerging disease, in addition to the recall bias when reporting the symptoms that occurred in latest.</p>
</sec>
</sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusions</title>
<p>The state of alarm decreed by the Spanish Government due to the COVID-19 pandemic had a negative impact on work and finances of public and private sector Spanish physical therapists. On the one hand, in the area of work, the modifications or the suspensions of the schedule appointments at private clinics, or the transfer of the health professionals to acute COVID-19 patient hospitals were some of the most notable (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>On the other hand, in economic terms, the fear of infection of the patient and the imposition of safety measures compromised these private businesses. The aid offered by the Government was not enough to cover the needs of the physical therapists during the state of alarm period. Our study suggests the need to perform exhaustive qualitative analyses of the negative economic impact exerted by the pandemic, both in the past and presently, on the Spanish physical therapists during and after the pandemic. These studies could allow us to reflect on the efficacy of the aid offered to health professionals during the pandemic by the Government, to improve the actions taken during future, similar health emergencies, as well as to create new measures that will accelerate the post-pandemic economic recovery.</p>
<p>The vaccine was widely accepted by the Spanish physical therapists, improving the percentages estimated at the start of the vaccination campaign, and was not only influenced by the worry about their own health or that of the community at large, but by the economic impact that an infection in the work setting could signify.</p>
<p>However, the appearance of adverse effects during the vaccination campaign, and the discrepancy between political and health authorities when defining the vaccination strategy, increased the health professional&#x00027;s doubts for receiving the second dose. In this sense, the correct coordination between the different organizations and communication media during the vaccination campaign is indispensable for the health professionals to be able to offer the general population information that is precise, reliable, and trustworthy.</p>
</sec>
<sec sec-type="data-availability" id="s6">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by Ethics Committee from the CEU Cardenal-Herrera University (Refrence:CEI21/060). The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>JS-M, JT, and NR-B: conceptualization and writing&#x02014;review and editing. SM-N, JS-M, CS-A, CO-R, and JB-R: investigation and data curation. JS-M: statistical analysis. SM-N, JS-M, FM-P, and NR-B: writing&#x02014;original draft. All authors contributed substantially to the study design data analysis and interpretation of the findings.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This study recieved funding for open access publication fees from CEU-Cardenal Herrera University.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>We would like to thank the Illustrious Official Association of Physical Therapists from the Community of Valencia and the General Council of Physical Therapist Associations of Spain for the collaboration in the dissemination the questionnaire among the Spanish physical therapists. We also want to thank the translator Mario for his work.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Naming the coronavirus disease (COVID-19) and the virus that causes it</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Listings of WHO&#x00027;s response to COVID-19</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news/item/29-06-2020-covidtimeline">https://www.who.int/news/item/29-06-2020-covidtimeline</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Ministerio de Sanidad - Profesionales - Estrategia de vacunaci&#x000F3;n COVID-19 en Espa&#x000F1;a</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/vacunaCovid19.htm">https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/vacunaCovid19.htm</ext-link> (accessed February 11, 2022).</citation>
</ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Ministerio de la Presidencia Relaciones con las Cortes y Memoria Democr&#x000E1;tica</collab></person-group>. <article-title>Real Decreto 463/2020, de 14 de marzo, por el que se declara el estado de alarma para la gesti&#x000F3;n de la situaci&#x000F3;n de crisis sanitaria ocasionada por el COVID-19</article-title>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.boe.es/eli/es/rd/2020/03/14/463">https://www.boe.es/eli/es/rd/2020/03/14/463</ext-link> (accessed October 20, 2021).</citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname> <given-names>YT</given-names></name> <name><surname>Yang</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>Q</given-names></name> <name><surname>Cheung</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed</article-title>. <source>Lancet Psychiatry.</source> (<year>2020</year>) <volume>7</volume>:<fpage>228</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(20)30046-8</pub-id><pub-id pub-id-type="pmid">32032543</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname> <given-names>M</given-names></name> <name><surname>Uddin</surname> <given-names>Z</given-names></name> <name><surname>Hossain</surname> <given-names>A</given-names></name></person-group>. <article-title>Economic stressors and mental health symptoms among Bangladeshi rehabilitation professionals: a cross-sectional study amid COVID-19 pandemic</article-title>. <source>Heliyon</source>. (<year>2021</year>) <volume>7</volume>:<fpage>6715</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e06715</pub-id><pub-id pub-id-type="pmid">33898834</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pegorari</surname> <given-names>MS</given-names></name> <name><surname>Ohara</surname> <given-names>DG</given-names></name> <name><surname>Matos</surname> <given-names>AP</given-names></name> <name><surname>Iosimuta</surname> <given-names>N</given-names></name> <name><surname>TK Ferreira</surname> <given-names>V</given-names></name> <name><surname>Carolina PN Pinto</surname> <given-names>A</given-names></name></person-group>. <article-title>Barriers and challenges faced by Brazilian physiotherapists during the COVID-19 pandemic and innovative solutions: lessons learned and to be shared with other countries</article-title>. <source>Physiotherapy Theory Prac</source>. (<year>2020</year>) <volume>36</volume>:<fpage>1069</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1080/09593985.2020.1818486</pub-id><pub-id pub-id-type="pmid">32896203</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association</collab></person-group>. <article-title>An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)</article-title>. <source>Zhonghua Liu Xing Bing Xue Za Zhi</source>. (<year>2020</year>) <volume>41</volume>:<fpage>139</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0254-6450.2020.02.002</pub-id><pub-id pub-id-type="pmid">32057211</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khurshid</surname> <given-names>Z</given-names></name> <name><surname>Asiri</surname> <given-names>FYI</given-names></name> <name><surname>Al Wadaani</surname> <given-names>H</given-names></name></person-group>. <article-title>Human saliva: non-invasive fluid for detecting novel coronavirus (2019-nCoV)</article-title>. <source>Int J Environ Res Public Health.</source> (<year>2020</year>) <volume>17</volume>:<fpage>2225</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17072225</pub-id><pub-id pub-id-type="pmid">32224986</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lystad</surname> <given-names>RP</given-names></name> <name><surname>Brown</surname> <given-names>BT</given-names></name> <name><surname>Swain</surname> <given-names>MS</given-names></name> <name><surname>Engel</surname> <given-names>RM</given-names></name></person-group>. <article-title>Impact of the COVID-19 Pandemic on manual therapy service utilization within the australian private healthcare setting</article-title>. <source>Healthcare.</source> (<year>2020</year>) <volume>8</volume>:<fpage>40558</fpage>. <pub-id pub-id-type="doi">10.3390/healthcare8040558</pub-id><pub-id pub-id-type="pmid">33322226</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>La</surname> <given-names>Moncloa</given-names></name></person-group>. <article-title>28/04/2020. Plan de desescalada [Consejo de Ministros]</article-title>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.lamoncloa.gob.es/consejodeministros/Paginas/enlaces/280420-enlace-desescalada.aspx">https://www.lamoncloa.gob.es/consejodeministros/Paginas/enlaces/280420-enlace-desescalada.aspx</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Jefatura del Estado</collab></person-group>. <article-title>Real Decreto-ley 8/2021, de 4 de mayo, por el que se adoptan medidas urgentes en el orden sanitario, social y jurisdiccional, a aplicar tras la finalizaci&#x000F3;n de la vigencia del estado de alarma declarado por el Real Decreto 926/2020, de 25 de octubre, por el que se declara el estado de alarma para contener la propagaci&#x000F3;n de infecciones causadas por el SARS-CoV-2</article-title>. (<year>2021</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.boe.es/eli/es/rdl/2021/05/04/8">https://www.boe.es/eli/es/rdl/2021/05/04/8</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Jefatura</surname> <given-names>del Estado</given-names></name></person-group>. <article-title>Real Decreto-ley 15/2020, de 21 de abril, de medidas urgentes complementarias para apoyar la econom&#x000ED;a y el empleo</article-title>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.boe.es/eli/es/rdl/2020/04/21/15">https://www.boe.es/eli/es/rdl/2020/04/21/15</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Jefatura</surname> <given-names>del Estado</given-names></name></person-group>. <article-title>Real Decreto-ley 9/2020, de 27 de marzo, por el que se adoptan medidas complementarias, en el &#x000E1;mbito laboral, para paliar los efectos derivados del COVID-19</article-title>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.boe.es/eli/es/rdl/2020/03/27/9">https://www.boe.es/eli/es/rdl/2020/03/27/9</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Jefatura</surname> <given-names>del Estado</given-names></name></person-group>. <article-title>Real Decreto-ley 10/2020, de 29 de marzo, por el que se regula un permiso retribuido recuperable para las personas trabajadoras por cuenta ajena que no presten servicios esenciales, con el fin de reducir la movilidad de la poblaci&#x000F3;n en el contexto de la lucha contra el COVID-19</article-title>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.boe.es/eli/es/rdl/2020/03/29/10">https://www.boe.es/eli/es/rdl/2020/03/29/10</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Gomes</surname> <given-names>MGM</given-names></name> <name><surname>Aguas</surname> <given-names>R</given-names></name> <name><surname>King</surname> <given-names>JG</given-names></name> <name><surname>Langwig</surname> <given-names>KE</given-names></name> <name><surname>Souto-Maior</surname> <given-names>C</given-names></name> <name><surname>Carneiro</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold</article-title>. <source>medRxiv</source>. (<year>2021</year>). <pub-id pub-id-type="doi">10.1101/2020.04.27.20081893</pub-id><pub-id pub-id-type="pmid">35189135</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>El Ministerio de Sanidad suspende a partir de ma&#x000F1;ana y durante las dos pr&#x000F3;ximas semanas la vacunaci&#x000F3;n con la vacuna frente a la COVID-19 de AstraZeneca</collab></person-group>. <article-title>Agencia Espa&#x000F1;ola de Medicamentos y Productos Sanitarios</article-title> (<year>2021</year>) Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2021-seguridad-1/el-ministerio-de-sanidad-suspende-a-partir-de-manana-y-durante-las-dos-proximas-semanas-la-vacunacion-con-la-vacuna-frente-a-la-covid-19-de-astrazeneca/">https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2021-seguridad-1/el-ministerio-de-sanidad-suspende-a-partir-de-manana-y-durante-las-dos-proximas-semanas-la-vacunacion-con-la-vacuna-frente-a-la-covid-19-de-astrazeneca/</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="web"><collab>COVID-19_Actualizacion7_EstrategiaVacunacion.pdf</collab>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/COVID-19_Actualizacion7_EstrategiaVacunacion.pdf">https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/COVID-19_Actualizacion7_EstrategiaVacunacion.pdf</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Consejo General de Colegios de Fisioterapeutas de Espa&#x000F1;a</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.consejo-fisioterapia.org/vu_colegiados/pag_1.html">https://www.consejo-fisioterapia.org/vu_colegiados/pag_1.html</ext-link> (accessed February 11, 2022).</citation>
</ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>Rodr22ryz-Blanco N Montero-Navarro S Botella-Rico JM Felipe-Gion/vacunaciones/coviroximas-semanas-la-vacunaciobe Felipe-Gion/vacunaciones/coviroximas-semanas-la-vacunaciobe vaccinated against COVID-19 in Spain before the start of vaccination: a cross-sectional study</collab></person-group>. <source>Int J Environ Res Public Health.</source> (<year>2021</year>) <volume>18</volume>:<fpage>5272</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18105272</pub-id><pub-id pub-id-type="pmid">34063476</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lucaciu</surname> <given-names>O</given-names></name> <name><surname>Boca</surname> <given-names>A</given-names></name> <name><surname>Mesaros</surname> <given-names>AS</given-names></name> <name><surname>Petrescu</surname> <given-names>N</given-names></name> <name><surname>Aghiorghiesei</surname> <given-names>O</given-names></name> <name><surname>Mirica</surname> <given-names>IC</given-names></name> <etal/></person-group>. <article-title>Assessing SARS-CoV-2 infection rate among romanian dental practitioners</article-title>. <source>Int J Environ Res Public Health.</source> (<year>2021</year>) <volume>18</volume>:<fpage>4897</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18094897</pub-id><pub-id pub-id-type="pmid">34064469</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Association MGM</collab></person-group>. <article-title>Quantifying the pandemic: the impact COVID-19 had on medical practices in 2020</article-title>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.prnewswire.com/news-releases/quantifying-the-pandemic-the-impact-covid-19-had-on-medical-practices-in-2020-301286058.html">https://www.prnewswire.com/news-releases/quantifying-the-pandemic-the-impact-covid-19-had-on-medical-practices-in-2020-301286058.html</ext-link> (accessed November 24, 2021).</citation>
</ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmulson</surname> <given-names>M</given-names></name></person-group> <article-title>Gudiswire.com/news-releases/quantifying-the-pandemic-the-impacThe impact of COVID-19 Pandemic on Neurogastroenterologists in Latin America: results of an online survey</article-title>. <source>J Clin Gastroenterol.</source> (<year>2021</year>) <volume>55</volume>:<fpage>684</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1097/MCG.0000000000001413</pub-id><pub-id pub-id-type="pmid">33471492</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahdee</surname> <given-names>AF</given-names></name> <name><surname>Gul</surname> <given-names>SS</given-names></name> <name><surname>Abdulkareem</surname> <given-names>AA</given-names></name> <name><surname>Qasim</surname> <given-names>SSB</given-names></name></person-group>. <article-title>Anxiety, practice modification, and economic impact among iraqi dentists during the COVID-19 outbreak</article-title>. <source>Front Med.</source> (<year>2020</year>) <volume>7</volume>:<fpage>595028</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2020.595028</pub-id><pub-id pub-id-type="pmid">33425944</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chamorro-Petronacci</surname> <given-names>C</given-names></name> <name><surname>Martin Carreras-Presas</surname> <given-names>C</given-names></name> <name><surname>Sanz-Marchena</surname> <given-names>A</given-names></name> <name><surname>A Rodr&#x000ED;guez-Fern&#x000E1;ndez</surname> <given-names>M</given-names></name> <name><surname>Mar&#x000ED;a Su&#x000E1;rez-Quintanilla</surname> <given-names>J</given-names></name> <name><surname>Rivas-Mundi&#x000F1;a</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Assessment of the economic and health-care impact of COVID-19 (SARS-CoV-2) on public and private dental surgeries in Spain: a pilot study</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>:<fpage>5139</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17145139</pub-id><pub-id pub-id-type="pmid">32708838</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowan</surname> <given-names>NJ</given-names></name> <name><surname>Laffey</surname> <given-names>JG</given-names></name></person-group>. <article-title>Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic) case study from the Republic of Ireland</article-title>. <source>Sci Total Environ.</source> (<year>2020</year>) <volume>725</volume>:<fpage>138532</fpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138532</pub-id><pub-id pub-id-type="pmid">32304970</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranney</surname> <given-names>ML</given-names></name> <name><surname>Griffeth</surname> <given-names>V</given-names></name> <name><surname>Jha</surname> <given-names>AK</given-names></name></person-group>. <article-title>Critical Supply shortages &#x02014;oThe need for ventilators and personal protective equipment during the Covid-19p</article-title>. <source>N Engl J Med.</source> (<year>2020</year>) <volume>382</volume>:<fpage>e41</fpage>. <pub-id pub-id-type="doi">10.1056/NEJMp2006141</pub-id><pub-id pub-id-type="pmid">32212516</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname> <given-names>S</given-names></name> <name><surname>Hossain</surname> <given-names>MM</given-names></name> <name><surname>Singh</surname> <given-names>A</given-names></name> <name><surname>Bhattacharya</surname> <given-names>S</given-names></name> <name><surname>Hossain</surname> <given-names>MM</given-names></name> <name><surname>Singh</surname> <given-names>A</given-names></name></person-group>. <article-title>Addressing the shortage of personal protective equipment during the COVID-19 pandemic in India-A public health perspective</article-title>. <source>AIMSPH.</source> (<year>2020</year>) <volume>7</volume>:<fpage>223</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3934/publichealth.2020019</pub-id><pub-id pub-id-type="pmid">32617351</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>ZZ</given-names></name> <name><surname>Xiao</surname> <given-names>Y</given-names></name> <name><surname>Su</surname> <given-names>C-W</given-names></name></person-group>. <article-title>Does COVID-19 Drive stock price bubbles in medical mask?</article-title> <source>Asian Economics Letters.</source> (<year>2021</year>) <volume>2</volume>:<fpage>22976</fpage>. <pub-id pub-id-type="doi">10.46557/001c.22976</pub-id></citation>
</ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez Lozano</surname> <given-names>R</given-names></name> <name><surname>Alcocer Ojeda</surname> <given-names>MA</given-names></name> <name><surname>Moreno Mart</surname> <given-names>S</given-names></name> <name><surname>Hossain</surname> <given-names>MM</given-names></name> <name><surname>Singh</surname> <given-names>A</given-names></name></person-group>. <article-title>Addressing the shortage of personal protective equipment during t<italic>Fisioterapia</italic></article-title>. (<year>2020</year>) <volume>42</volume>:<fpage>224</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ft.2020.05.001</pub-id><pub-id pub-id-type="pmid">32617351</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwendicke</surname> <given-names>F</given-names></name> <name><surname>Krois</surname> <given-names>J</given-names></name> <name><surname>Gomez</surname> <given-names>J</given-names></name></person-group>. <article-title>Impact of SARS-CoV2 (Covid-19) on dental practices: economic analysis</article-title>. <source>J Dent.</source> (<year>2020</year>) <volume>99</volume>:<fpage>103387</fpage>. <pub-id pub-id-type="doi">10.1016/j.jdent.2020.103387</pub-id><pub-id pub-id-type="pmid">32473182</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Ministerio de la Presidencia Relaciones con las Cortes y Memoria Democr&#x000E1;tica</collab></person-group>. <article-title>Real Decreto 465/2020, de 17 de marzo, por el que se modifica el Real Decreto 463/2020, de 14 de marzo, por el que se declara el estado de alarma para la gesti&#x000F3;n de la situaci&#x000F3;n de crisis sanitaria ocasionada por el COVID-19</article-title>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.boe.es/eli/es/rd/2020/03/17/465">https://www.boe.es/eli/es/rd/2020/03/17/465</ext-link> (accessed October 24, 2021).</citation>
</ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Jefatura del Estado</collab></person-group>. <article-title>Real Decreto-ley 1/2020, de 14 de enero, por el que se establece la revalorizaci&#x000F3;n y mantenimiento de las pensiones y prestaciones p&#x000FA;blicas del sistema de Seguridad Social</article-title>. (<year>2020</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.boe.es/eli/es/rdl/2020/01/14/1">https://www.boe.es/eli/es/rdl/2020/01/14/1</ext-link> (accessed October 24, 2021).</citation>
</ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="web">DECRETO, 44/2020, de 3 de abril de aprobaci&#x000F3;n de las bases reguladoras de concesi&#x000F3;n directa de ayudas urgentes a personas trabajadoras en r&#x000E9;gimen de aut&#x000F3;nomo afectadas por la, Covid-19,. - Conselleria de Econom&#x000ED;a Sostenible, Sectores Productivos, Comercio y Trabajo - Generalitat Valenciana. Conselleria de Econom&#x000ED;a Sostenible, Sectores Productivos, Comercio y Trabajo Available online at: <ext-link ext-link-type="uri" xlink:href="https://cindi.gva.es/ca/-/asset_publisher/s1S4pkEMwVlQ/content/decreto-44-2020-de-3-de-abril-de-aprobacion-de-las-bases-reguladoras-de-concesion-directa-de-ayudas-urgentes-a-personas-trabajadoras-en-regimen-de-aut">https://cindi.gva.es/ca/-/asset_publisher/s1S4pkEMwVlQ/content/decreto-44-2020-de-3-de-abril-de-aprobacion-de-las-bases-reguladoras-de-concesion-directa-de-ayudas-urgentes-a-personas-trabajadoras-en-regimen-de-aut</ext-link> (accessed October 24, 2021).</citation>
</ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="web">DECRETO, 58/2020, de 8 de, mayo, de aprobaci&#x000F3;n de bases reguladoras para la concesi&#x000F3;n directa de ayudas a trabajadores y trabajadoras acogidos a una reducci&#x000F3;n de jornada a consecuencia de la, Covid-19,. - Conselleria de Econom&#x000ED;a Sostenible, Sectores Productivos, Comercio y Trabajo - Generalitat Valenciana. Conselleria de Econom&#x000ED;a Sostenible, Sectores Productivos, Comercio y Trabajo. Available online at: <ext-link ext-link-type="uri" xlink:href="https://cindi.gva.es/ca/-/asset_publisher/s1S4pkEMwVlQ/content/decreto-58-2020-de-8-de-mayo-de-aprobacion-de-bases-reguladoras-para-la-concesion-directa-de-ayudas-a-trabajadores-y-trabajadoras-acogidos-a-una-reduc/21189">https://cindi.gva.es/ca/-/asset_publisher/s1S4pkEMwVlQ/content/decreto-58-2020-de-8-de-mayo-de-aprobacion-de-bases-reguladoras-para-la-concesion-directa-de-ayudas-a-trabajadores-y-trabajadoras-acogidos-a-una-reduc/21189</ext-link> (accessed October 24, 2021).</citation>
</ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>El ICOFCV contrata un Seguro de Hospitalizaci&#x000F3;n por COVID-19 para cuidar y proteger a sus colegiados | Ilustre Colegio Oficial de Fisioterapeutas de la Comunidad Valenciana</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.colfisiocv.com/Seguro_Hospitalizacion_COVID19">https://www.colfisiocv.com/Seguro_Hospitalizacion_COVID19</ext-link> (accessed October 26, 2021).</citation>
</ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Ministerio de Sanidad - Profesionales - Documentos t&#x000E9;cnicos para profesionales - Coronavirus</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos.htm">https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos.htm</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Iguacel</surname> <given-names>I</given-names></name> <name><surname>Luna Maldonado</surname> <given-names>A</given-names></name> <name><surname>Luna Ruiz-Cabello</surname> <given-names>A</given-names></name> <name><surname>Samat&#x000E1;n</surname> <given-names>E</given-names></name> <name><surname>Alarc&#x000F3;n</surname> <given-names>J</given-names></name> <name><surname>&#x000C1;ngeles Orte</surname> <given-names>M</given-names></name> <name><surname>Santodomingo Mateos</surname> <given-names>S</given-names></name> <name><surname>Mart&#x000ED;nez-Jarreta</surname> <given-names>B</given-names></name></person-group>. <article-title>Attitudes of Healthcare Professionals and General Population Toward Vaccines and the Intention to Be Vaccinated Against COVID-19 in Spain</article-title>. Frontiers in Public Health (<year>2021</year>) <fpage>9</fpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/article/10.3389/fpubh.2021.739003">https://www.frontiersin.org/article/10.3389/fpubh.2021.739003</ext-link> (accessed February 11, 2022).<pub-id pub-id-type="pmid">34692626</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>Eguia H Vinciarelli F Bosque-Prous M Kristensen T SaigE Alarc&#x000F3;n J &#x000C1;ngelhesitation &#x000C1;ngelhesitation at the gates of a COVID-19 vaccine</collab></person-group>. <source>Vaccines.</source> (<year>2021</year>) <volume>9</volume>:<fpage>170</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines9020170</pub-id><pub-id pub-id-type="pmid">33670621</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quiroga</surname> <given-names>B</given-names></name></person-group> <article-title>S: 10.lli F, Bosque-Prous M, Kristensen T, SaigE, Alarc&#x000F3;n J, &#x000C1;ngeles Orte M, Santodomingo Mateo: acceptance and side effects</article-title>. <source>J Healthcare Quality Res.</source> (<year>2021</year>) <volume>36</volume>:<fpage>170</fpage>.</citation>
</ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Crece la confianza en las vacunas contra la Covid</collab></person-group>. <article-title>ELMUNDO (2021)</article-title> Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.elmundo.es/ciencia-y-salud/salud/2021/02/18/602e54f621efa02f2e8b46e7.html">https://www.elmundo.es/ciencia-y-salud/salud/2021/02/18/602e54f621efa02f2e8b46e7.html</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>COVID-19: Willingness to be vaccinated | YouGov</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://yougov.co.uk/topics/international/articles-reports/2021/01/12/covid-19-willingness-be-vaccinated">https://yougov.co.uk/topics/international/articles-reports/2021/01/12/covid-19-willingness-be-vaccinated</ext-link> (accessed October 19, 2021).</citation>
</ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baden</surname> <given-names>LR</given-names></name> <name><surname>El Sahly</surname> <given-names>HM</given-names></name> <name><surname>Essink</surname> <given-names>B</given-names></name> <name><surname>Kotloff</surname> <given-names>K</given-names></name> <name><surname>Frey</surname> <given-names>S</given-names></name> <name><surname>Novak</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine</article-title>. <source>N Eng J Med.</source> (<year>2021</year>) <volume>384</volume>:<fpage>403</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2035389</pub-id><pub-id pub-id-type="pmid">33378609</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname> <given-names>S</given-names></name> <name><surname>Lee</surname> <given-names>YW</given-names></name> <name><surname>Lim</surname> <given-names>SY</given-names></name> <name><surname>Lee</surname> <given-names>JH</given-names></name> <name><surname>Lim</surname> <given-names>JS</given-names></name> <name><surname>Lee</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Adverse reactions following the first dose of ChAdOx1 nCoV-19 vaccine and BNT162b2 vaccine for healthcare workers in South Korea</article-title>. <source>J Korean Med Sci.</source> (<year>2021</year>) <volume>36</volume>:<fpage>e115</fpage>. <pub-id pub-id-type="doi">10.3346/jkms.2021.36.e115</pub-id><pub-id pub-id-type="pmid">33942579</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polack</surname> <given-names>FP</given-names></name> <name><surname>Thomas</surname> <given-names>SJ</given-names></name> <name><surname>Kitchin</surname> <given-names>N</given-names></name> <name><surname>Absalon</surname> <given-names>J</given-names></name> <name><surname>Gurtman</surname> <given-names>A</given-names></name> <name><surname>Lockhart</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine</article-title>. <source>N Eng J Med.</source> (<year>2020</year>) <volume>383</volume>:<fpage>2603</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2034577</pub-id><pub-id pub-id-type="pmid">33301246</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadali</surname> <given-names>RAK</given-names></name> <name><surname>Janagama</surname> <given-names>R</given-names></name> <name><surname>Peruru</surname> <given-names>S</given-names></name> <name><surname>Malayala</surname> <given-names>SV</given-names></name> <name><surname>Side</surname></name></person-group>. <article-title>effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers</article-title>. <source>Int J Infect Dis.</source> (<year>2021</year>) <volume>106</volume>:<fpage>376</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2021.04.047</pub-id><pub-id pub-id-type="pmid">33866000</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>L</given-names></name> <name><surname>McPhee</surname> <given-names>R</given-names></name> <name><surname>Huang</surname> <given-names>W</given-names></name> <name><surname>Bennett</surname> <given-names>H</given-names></name> <name><surname>Pajon</surname> <given-names>R</given-names></name> <name><surname>Nestorova</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>mRNA-1273 Study group. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine</article-title>. <source>Vaccine.</source> (<year>2021</year>) <volume>39</volume>:<fpage>2791</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2021.02.007</pub-id><pub-id pub-id-type="pmid">33707061</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMurry</surname> <given-names>R</given-names></name> <name><surname>Lenehan</surname> <given-names>P</given-names></name> <name><surname>Awasthi</surname> <given-names>S</given-names></name> <name><surname>Silvert</surname> <given-names>E</given-names></name> <name><surname>Puranik</surname> <given-names>A</given-names></name> <name><surname>Pawlowski</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines</article-title>. <source>Med</source>. (<year>2021</year>) <volume>2</volume>:<fpage>965</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.medj.2021.06.006</pub-id><pub-id pub-id-type="pmid">34230920</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potteg6rd</surname> <given-names>A</given-names></name> <name><surname>Lund</surname> <given-names>LC</given-names></name> <name><surname>Karlstad</surname></name> <collab>a mass vaccination effort confi</collab></person-group>. <article-title>Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study</article-title>. <source>BMJ.</source> (<year>2021</year>) <volume>373</volume>:<fpage>n1114</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.n1114</pub-id><pub-id pub-id-type="pmid">33952445</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greinacher</surname> <given-names>A</given-names></name> <name><surname>Thiele</surname> <given-names>T</given-names></name> <name><surname>Warkentin</surname> <given-names>TE</given-names></name> <name><surname>Weisser</surname> <given-names>K</given-names></name> <name><surname>Kyrle</surname> <given-names>PA</given-names></name> <name><surname>Eichinger</surname> <given-names>S</given-names></name></person-group>. <article-title>Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination</article-title>. <source>N Engl J Med.</source> (<year>2021</year>) <volume>384</volume>:<fpage>2092</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2104840</pub-id><pub-id pub-id-type="pmid">33835769</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>Europeans now see AstraZeneca vaccine as unsafe following blood clots scare | YouGov</collab></person-group>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://yougov.co.uk/topics/international/articles-reports/2021/03/22/europeans-now-see-astrazeneca-vaccine-unsafe-follo">https://yougov.co.uk/topics/international/articles-reports/2021/03/22/europeans-now-see-astrazeneca-vaccine-unsafe-follo</ext-link> (accessed October 20, 2021).</citation>
</ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="web"><collab>Nota_AZ_Informacion_personas_menores_60anos_vacunadas_una_dosis.pdf</collab>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Nota_AZ_Informacion_personas_menores_60anos_vacunadas_una_dosis.pdf">https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Nota_AZ_Informacion_personas_menores_60anos_vacunadas_una_dosis.pdf</ext-link> (accessed October 29, 2021).</citation>
</ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>EMA</collab></person-group>. <article-title>COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine&#x00027;s benefits currently still outweigh risks Update</article-title>. European Medicines Agency (<year>2021</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits">https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits</ext-link> (accessed October 20, 2021).</citation>
</ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palacios-Ce&#x000F1;a</surname> <given-names>D</given-names></name> <name><surname>Fern&#x000E1;ndez-de-las-Pe&#x000F1;as</surname> <given-names>C</given-names></name> <name><surname>Florencio</surname> <given-names>LL</given-names></name> <name><surname>Palacios-Ce&#x000F1;a</surname> <given-names>M</given-names></name> <name><surname>de-la-Llave-Rinc&#x000F3;n</surname> <given-names>AI</given-names></name></person-group>. <article-title>Future challenges for physical therapy during and after the COVID-19 pandemic: a qualitative study on the experience of physical therapists in Spain</article-title>. <source>Int J Environ Res Public Health.</source> (<year>2021</year>) <volume>18</volume>:<fpage>8368</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18168368</pub-id> <pub-id pub-id-type="pmid">34444118</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>AZ</term>
<def><p>AstraZeneca-Oxford</p></def></def-item>
<def-item><term>CI</term>
<def><p>confidence interval</p></def></def-item>
<def-item><term>Mo</term>
<def><p>Moderna</p></def></def-item>
<def-item><term>OR</term>
<def><p>Odds ratio</p></def></def-item>
<def-item><term>PB</term>
<def><p>Pfizer-BioNTech</p></def></def-item>
<def-item><term>PPE</term>
<def><p>personal protection equipment</p></def></def-item>
<def-item><term>WHO</term>
<def><p>World Health Organization.</p></def></def-item>
</def-list>
</glossary>
</back>
</article>